AIDS Malignancy Consortium (AMC) - International Protocol Development Support

$78,040UM1FY2025CANIH

Icahn School Of Medicine At Mount Sinai, New York NY

Investigators

Linked publications, trials & patents

Paper 39431505 Paper 39334203 Paper 39031851 Paper 38635762 Paper 38504387 Paper 38190392 Paper 37962072 Paper 37805952 Paper 37523145 Paper 37389844 Paper 37187125 Paper 37020153 Paper 36795989 Paper 36786605 Paper 36493958 Paper 36219358 Paper 36201743 Paper 36048901 Paper 35772043 Paper 35704479 Paper 35655072 Paper 35466960 Paper 35429391 Paper 35325151 Paper 35247913 Paper 35234354 Paper 35152042 Paper 35017115 Paper 34907980 Paper 34539628 Paper 34499351 Paper 34479367 Paper 34339628 Paper 34339099 Paper 34303416 Paper 34131000 Paper 34110312 Paper 34087151 Paper 34056930 Paper 34049357 Paper 33991185 Paper 33909482 Paper 33677480 Paper 33037426 Paper 32846272 Paper 32791045 Paper 32697667 Paper 32634068 Paper 32421978 Paper 32265361 Paper 32145827 Paper 32107337 Paper 32080349 Paper 31977596 Paper 31742639 Paper 31705618 Paper 31624104 Paper 31512168 Paper 31322992 Paper 31292602 Paper 30940485 Paper 30890062 Paper 30862694 Paper 30796065 Paper 30773222 Paper 30705286 Paper 30617704 Paper 30573564 Paper 30450671 Trial NCT07662928 Trial NCT07649304 Trial NCT07539454 Trial NCT05797662 Trial NCT05663502 Trial NCT05510908 Trial NCT05077527 Trial NCT04949464 Trial NCT04929028 Trial NCT04704648 Trial NCT04577755 Trial NCT04305691 Trial NCT04276935 Trial NCT04142398 Trial NCT04142385 Trial NCT04139304 Trial NCT04089488 Trial NCT03834571 Trial NCT03603808 Trial NCT03601806 Trial NCT03596918 Trial NCT03284866 Trial NCT03220022 Trial NCT03077451 Trial NCT02408861 Trial NCT02135419 Trial NCT01822522 Trial NCT01771107 Trial NCT01590017 Trial NCT01193842 Trial NCT01016730

Abstract

Abstract/Lay Summary The AIDS Malignancy Consortium (AMC) was established in 1995 and has been at the forefront of the clinical evaluation of interventions for the treatment and prevention of malignancies in people living with the human immunodeficiency virus (PLWH). The consortium includes 10 international trial sites located in 6 countries in sub-Saharan Africa (including 6 sites in South Africa, Kenya, Zimbabwe, Uganda, and Malawi) and Latin America (including 4 sites in Mexico, Brazil, and Argentina). The supplement to the AMC grant (2UM1CA121947) will support convening an expert group of scientific reviewers to provide peer review of approximately 2-4 AMC clinical trials annually that will involve patient accrual from the 10 AMC international sites.

View original record on NIH RePORTER →